Hi GW,
To be honest if I was just a punter I would wait till see if we get an approval. You will pay considerably more but the real money is after we get
the FDA nod with our other indications.
Its a bit different for some on here we have been following the story and
feel confident.
I just can not see Krause joining the Board , guiding the company thru the submission and then getting a negative decision.
Also is it possible Krause personally knows people that will look at the submission. Not sure if thats applicable but I wonder.
Aloha.
Ann: Biotech Showcase 2023 Presentation in San Francisco, page-165
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.44 |
Change
-0.010(0.69%) |
Mkt cap ! $1.644B | |||
| Open | High | Low | Value | Volume |
| $1.50 | $1.50 | $1.43 | $4.048M | 2.778M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 26808 | $1.44 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.45 | 16001 | 1 |
View Market Depth
| Last trade - 16.10pm 14/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |